Results 91 to 100 of about 16,159 (251)

Primary ciliary dyskinesia: mechanisms and management

, 2017
Nadirah Damseh,1 Nada Quercia,1,2 Nisreen Rumman,3 Sharon D Dell,4 Raymond H Kim5 1Division of Clinical and Metabolic Genetics, 2Department of Molecular Genetics, University of Toronto, Toronto, ON, Canada; 3Pediatric Department, Makassed Hospital ...
Kim RH, Damseh N, Dell SD, Rumman N, Quercia N   +4 more
core  

Safinamide in the management of patients with Parkinson’s disease not stabilized on levodopa: a review of the current clinical evidence

Therapeutics and Clinical Risk Management, 2018
Sagari Bette, Danielle S Shpiner, Carlos Singer, Henry Moore Department of Neurology, Division of Parkinson’s Disease and Movement Disorders, University of Miami – Miller School of Medicine, Miami, FL, USA Abstract: Safinamide (Xadago®)
Bette S, Shpiner DS, Singer C, Moore H
doaj  

Botulinum therapy for writing spasm

Якутский медицинский журнал
The article presents a clinical case of graphospasm - focal dystonia, in which the motor function of the dominant hand is disturbed, which manifests itself mainly when writing and small movements of the hand and gradually leads to disability.
A. E. Adamova, P. S. Nazarova, T. K. Davydova   +2 more
doaj   +1 more source

Automatic Spiral Analysis for Objective Assessment of Motor Symptoms in Parkinson’s Disease

Sensors, 2015
A challenge for the clinical management of advanced Parkinson’s disease (PD) patients is the emergence of fluctuations in motor performance, which represents a significant source of disability during activities of daily living of the patients. There is a
Mevludin Memedi, Aleksander Sadikov, Vida Groznik, Jure Žabkar, Martin Možina, Filip Bergquist, Anders Johansson, Dietrich Haubenberger, Dag Nyholm   +8 more
doaj   +1 more source

Tardive dyskinesia

, 2020
Tardive dyskinesia is now widely recognised as a neurological disorder associated with the administration of antipsychotic drugs. Prevalence is higher among the elderly.
Blowers, Anthony John
core  

Data‐Driven Insights into Hyperkinetic Disorders in Neurodevelopmental Syndromes and Epileptic Encephalopathies

Movement Disorders Clinical Practice, EarlyView.
Abstract Background Childhood‐onset hyperkinetic movement disorders occur in a range of genetic conditions. Recently, there has been an increase in recognition of hyperkinetic movement disorders, mainly dystonia, chorea and dyskinesia, with monogenic conditions associated with neurodevelopmental delay (NDD) and also with developmental and epileptic ...
Hugo Morales‐Briceño, Shekeeb S. Mohammad, Rajeshwar Reddy Angiti, Velda Han, Michel Tchan, Russell C. Dale, Victor S.C. Fung   +6 more
wiley   +1 more source

Targeting the D1-N-methyl-D-aspartate receptor complex reduces L-dopa-induced dyskinesia in 6-hydroxydopamine-lesioned Parkinson’s rats

Drug Design, Development and Therapy, 2016
Lu Song,1,* Zhanzhao Zhang,2,* Rongguo Hu,1 Jie Cheng,1 Lin Li,1 Qinyi Fan,1 Na Wu,1 Jing Gan,1 Mingzhu Zhou,1 Zhenguo Liu11Department of Neurology, Xinhua Hospital, 2Department of Plastic and Reconstructive Surgery, Shanghai 9th People’s Hospital,
Song L, Zhang ZZ, Hu RG, Cheng J, Li L, Fan QY, Wu N, Gan J, Zhou MZ, Liu ZG   +9 more
doaj  

New and emerging treatments for symptomatic tardive dyskinesia

, 2013
Abdul Qayyum Rana,1–4 Zishan M Chaudry,5 Pierre J Blanchet6 1Parkinson's Clinic of Eastern Toronto and Movement Disorders Centre, Toronto, ON, Canada; 2Scarborough Memory Program, Toronto, ON, Canada; 3Journal of Parkinsonism and RLS, Toronto ...
Rana AQ, Chaudry ZM, Blanchet PJ
core  

Placebo Effect in Levodopa‐Induced Dyskinesia: A Systematic Review and Meta‐Analysis

Movement Disorders Clinical Practice, EarlyView.
Abstract Background Levodopa‐induced dyskinesia (LID) is a complication of Parkinson's disease (PD) treatment. While the placebo effect is a known component in PD clinical trials, its specific magnitude in the context of LID is not well characterized.
Luiz Vinicius Silva Correa, Alexandre Martins do Nascimento, Bruno Lopes Santos‐Lobato, Henry Mauricio Chaparro‐Solano, Ignacio Fernandez Mata, Vitor Tumas   +5 more
wiley   +1 more source

Reversible Orofacial Dyskinesia Associated with Venlafaxine

Indian Journal of Medical Specialities
Venlafaxine, a widely used serotonin–noradrenaline reuptake inhibitor, is generally well tolerated but has occasionally been associated with extrapyramidal symptoms.
Ateeba Ahmed, Pradeep Shriram Patil
doaj   +1 more source